A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage (Q38949554)

7 September 2017

title

A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage (English)

1 reference

7 September 2017

0 references

Jean-Pierre Vartanian

object named as

Jean-Pierre Vartanian

4

0 references

author name string

Vincent Caval

1

1 reference

7 September 2017

Rodolphe Suspène

2

1 reference

7 September 2017

Milana Shapira

3

1 reference

7 September 2017

Simon Wain-Hobson

5

1 reference

7 September 2017

language of work or name

English

0 references

publication date

9 October 2014

1 reference

7 September 2017

published in

Nature Communications

1 reference

7 September 2017

volume

5

1 reference

7 September 2017

page(s)

5129

1 reference

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

APOBEC3A can activate the DNA damage response and cause cell-cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Patterns of somatic mutation in human cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Mutational processes molding the genomes of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Complex landscapes of somatic rearrangement in human breast cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Clustered and genome-wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

APOBEC3B is an enzymatic source of mutation in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

A common deletion in the APOBEC3 genes and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Population stratification of a common APOBEC gene deletion polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

APOBEC3 proteins mediate the clearance of foreign DNA from human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

A biochemical analysis linking APOBEC3A to disparate HIV-1 restriction and skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

The landscape of cancer genes and mutational processes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

inferred from DOI database lookup

7 January 2021

based on heuristic

Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6129

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCOMMS6129

1 reference

Dimensions Publication ID

7 September 2017

0 references

1050779071

0 references

1 reference